|
Neoplasia
Citations 121-130 of 4217 total displayed.
|
Past content
(since Jan 1997):
|
The Mll partial tandem duplication: differential, tissue-specific activity in the presence or absence of the wild-type allele
- Adrienne M. Dorrance, Shujun Liu, Anita Chong, Benjamin Pulley, David Nemer, Martin Guimond, Weifeng Yuan, Dennis Chang, Susan P. Whitman, Guido Marcucci, and Michael A. Caligiuri
Blood 2008; 112: 2508-2511.
[Abstract]
[Full text]
[PDF]
Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature
- Andreas A. Argyriou, Gregoris Iconomou, and Haralabos P. Kalofonos
Blood 2008; 112: 1593-1599.
[Abstract]
[Full text]
[PDF]
European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas
- Nancy J. Senff, Evert M. Noordijk, Youn H. Kim, Martine Bagot, Emilio Berti, Lorenzo Cerroni, Reinhard Dummer, Madeleine Duvic, Richard T. Hoppe, Nicola Pimpinelli, Steven T. Rosen, Maarten H. Vermeer, Sean Whittaker, and Rein Willemze
Blood 2008; 112: 1600-1609.
[Abstract]
[Full text]
[PDF]
The natural history and treatment outcome of blast phase BCR-ABL– myeloproliferative neoplasms
- Constantine S. Tam, Roberto M. Nussenzveig, Uday Popat, Carlos E. Bueso-Ramos, Deborah A. Thomas, Jorge A. Cortes, Richard E. Champlin, Stefan E. Ciurea, Taghi Manshouri, Sherry M. Pierce, Hagop M. Kantarjian, and Srdan Verstovsek
Blood 2008; 112: 1628-1637.
[Abstract]
[Full text]
[PDF]
A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome
- Stefan Faderl, Farhad Ravandi, Xuelin Huang, Guillermo Garcia-Manero, Alessandra Ferrajoli, Zeev Estrov, Gautam Borthakur, Srdan Verstovsek, Deborah A. Thomas, Monica Kwari, and Hagop M. Kantarjian
Blood 2008; 112: 1638-1645.
[Abstract]
[Full text]
[PDF]
What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies
- Wendy Stock, Mei La, Ben Sanford, Clara D. Bloomfield, James W. Vardiman, Paul Gaynon, Richard A. Larson, and James Nachman
Blood 2008; 112: 1646-1654.
[Abstract]
[Full text]
[PDF]
Successful treatment of progressive cutaneous mastocytosis with imatinib in a 2-year-old boy carrying a somatic KIT mutation
- Karl M. Hoffmann, Andrea Moser, Peter Lohse, Andreas Winkler, Barbara Binder, Petra Sovinz, Herwig Lackner, Wolfgang Schwinger, Martin Benesch, and Christian Urban
Blood 2008; 112: 1655-1657.
[Abstract]
[Full text]
[PDF]
Tetraspanin family member CD9 inhibits Aggrus/podoplanin-induced platelet aggregation and suppresses pulmonary metastasis
- Youya Nakazawa, Shigeo Sato, Mikihiko Naito, Yukinari Kato, Kazuhiko Mishima, Hiroyuki Arai, Takashi Tsuruo, and Naoya Fujita
Blood 2008; 112: 1730-1739.
[Abstract]
[Full text]
[PDF]
Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemia
- Concetta Quintarelli, Gianpietro Dotti, Biagio De Angelis, Valentina Hoyos, Martha Mims, Luigia Luciano, Helen E. Heslop, Cliona M. Rooney, Fabrizio Pane, and Barbara Savoldo
Blood 2008; 112: 1876-1885.
[Abstract]
[Full text]
[PDF]
HDAC6 inhibition enhances 17-AAG–mediated abrogation of hsp90 chaperone function in human leukemia cells
- Rekha Rao, Warren Fiskus, Yonghua Yang, Pearl Lee, Rajeshree Joshi, Pravina Fernandez, Aditya Mandawat, Peter Atadja, James E. Bradner, and Kapil Bhalla
Blood 2008; 112: 1886-1893.
[Abstract]
[Full text]
[PDF]
|
|
